Japan Enters Taiwan-China Fight With Vaccine Shipment to Taipei
(Bloomberg) -- Japan sent some of its Covid-19 vaccines to Taiwan, which has been struggling to procure its own supplies and blamed China for impeding shipments of the shots.
Foreign Minister Toshimitsu Motegi told reporters Japan provided about 1.24 million doses of the AstraZeneca Plc vaccine free of charge. The shipment arrived on a flight Friday and Taiwan's Ministry of Foreign Affairs offered its appreciation in a statement.
Motegi reiterated that Taiwan has an urgent need for supplies of the vaccine as Covid spreads and domestic production is not set to be ramped up until July. “We decided to provide this based on our important partnership with Taiwan and our friendship,” Motegi said, adding many in Japan remembered that Taiwan was the first to offer support after it was hit by a devastating earthquake and tsunami in 2011.
The shortage amid rising case numbers in Taiwan has raised fears of a health crisis that could hurt its semiconductor production, which is crucial for global industry. Donating the vaccines to Taiwan could irritate China, Japan's biggest trading partner, which sees the island as part of its territory and has stepped up military exercises in the region in recent months.
World's Supply of Chips Is in Danger Unless Taiwan Gets Vaccines
The government of Taiwan President Tsai Ing-wen has resisted pressure, both at home and from China, to work with Beijing to obtain Covid-19 vaccines, a politically unpalatable option for officials in Taipei. Tsai and her party have blamed China for scuttling an earlier order of millions of Pfizer Inc.-BioNTech SE shots, although Beijing has rejected the accusation.
China's Foreign Ministry sidestepped a question about Japan's role, but lashed out at Taipei. “The Taiwan authorities out of their own selfish political gains have engaged in political manipulation on vaccine issues,” ministry spokesman Wang Wenbin said at a regular press briefing in Beijing on Friday.
Japan approved the AstraZeneca vaccine on May 20 following domestic testing, but put its use on hold because of concerns about rare cases of blood clots. The government has sufficient supplies of other shots to cover its own population and on Wednesday hosted a summit aimed at accelerating global vaccination efforts.
Terry Gou, the founder of iPhone assembler Hon Hai Precision Industry Co., is working with Taiwan's health ministry to negotiate the purchase of BioNTech vaccines, Foreign Minister Joseph Wu said in a video press conference with the Foreign Correspondents' Club of Japan Thursday. Wu added that Tsai's administration welcomes any individuals or organizations that want to work with the government to secure vaccines for Taiwan.
Taiwan stands to receive vaccines from the U.S. The administration of President Joe Biden plans to distribute globally 25 million Covid-19 vaccine doses, with 7 million destined for Asia.
Taiwan has so far been unable to directly obtain Pfizer-BioNTech vaccines from Shanghai Fosun Pharmaceutical Group Co. The China-based drugmaker, which has an agreement to develop and distribute them in the greater China region that includes Hong Kong, Macau and Taiwan, has repeatedly said it wants to supply the BioNTech vaccine to Taiwan.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.